PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-10-10

Date Title Company
10-Oct-2024 Global Prurigo Nodularis Treatment Market Set to Expand, Reaching USD 930.9 Million by 2033 Growing at a 3.0% CAGR   MARKITWIRED
10-Oct-2024 Global Bone Screw System Market Set for Steady Growth, Projected to Reach USD 3,001.80 Million by 2034 MARKITWIRED
10-Oct-2024 Global Bioprocessing Analytics Equipment Market Poised for Exponential Growth Projections Indicate Surge USD 633.6 Million by 2028 MARKITWIRED
10-Oct-2024 Global Orthopedic Prosthetics Market Set for Significant Growth, Projected to Reach USD 3,908.2 Million by 2034 Expanding at a 5% CAGR MARKITWIRED
10-Oct-2024 Global Drug Designing Tools Market to Surge with 8.7% CAGR from 2023 to 2033 MARKITWIRED
10-Oct-2024 Global Dialysis Equipment Market Projected to reach a value of USD 17,780.9 million by 2034 MARKITWIRED
10-Oct-2024 Global Pulmonary Arterial Hypertension Treatment Market Projected to Reach USD 7,224.4 Million by 2033 MARKITWIRED
10-Oct-2024 CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products AccessWire
10-Oct-2024 Interactive Strength Inc. (NASDAQ:TRNR) Wins New Customer for CLMBR with Fast-growing 60 Location Chuze Fitness AccessWire
10-Oct-2024 CNX Therapeutics CEO Guy Clark Awarded “CEO of the Year” at CPHI Pharma Awards CNX Therapeutics
10-Oct-2024 Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation Pharming Group
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics
10-Oct-2024 Valneva Scotland supports local cancer charity Team Jak Foundation Valneva Scotland
10-Oct-2024 NICE lifts restriction and recommends bispecific antibody TECVAYLI®▼ (teclistamab) for all eligible patients with relapsed and refractory multiple myeloma after three treatments Johnson & Johnson
10-Oct-2024 Demonstrating the potential of flow biocatalysis Vapourtec
10-Oct-2024 Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab) SC-based quadruplet regimen for newly diagnosed multiple myeloma patients Johnson & Johnson
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics
10-Oct-2024 Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology Aenitis
10-Oct-2024 New Study Demonstrates Scalp Cooling Efficacy in Reducing Persistent Chemotherapy-Induced Alopecia Paxman
10-Oct-2024 FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer FluoGuide A/S